The effect of the mobile "blood pressure management application" on hypertension self-management enhancement: a randomized controlled trial.
Hypertension
Medication adherence
Mobile health
Self-management
mHealth
Journal
Trials
ISSN: 1745-6215
Titre abrégé: Trials
Pays: England
ID NLM: 101263253
Informations de publication
Date de publication:
24 Jun 2021
24 Jun 2021
Historique:
received:
02
04
2019
accepted:
13
04
2021
entrez:
25
6
2021
pubmed:
26
6
2021
medline:
29
6
2021
Statut:
epublish
Résumé
Self-management of hypertension is of great significance given its increasing incidence and its associated disabilities. In view of the increased use of mobile health in medicine, the present study evaluated the effect of a self-management application on patient adherence to hypertension treatment. This clinical trial was performed on 120 hypertensive patients who were provided with a mobile intervention for 8 weeks and followed up until the 24th week. Data on the primary outcome (adherence to treatment) and secondary outcomes (adherence to the DASH diet, regular monitoring of blood pressure, and physical activity) were collected using a questionnaire and a mobile application, respectively. The inter-group change difference over time was analyzed using repeated measures ANOVA (general linear model). The treatment adherence score increased by an average of 5.9 (95% CI 5.0-6.7) in the intervention group compared to the control group. The scores of "adherence to the low-fat and low-salt diet plans" were 1.7 (95% CI 1.3-2.1) and 1.5 (95% CI 1.2-1.9), respectively. Moreover, moderate physical activity increased to 100.0 min (95% CI 61.7-138.3) per week in the intervention group. The treatment and control of blood pressure require a multifaceted approach given its complexity and multifactorial nature. Considering the widespread use of smartphones, mHealth interventions can be effective in self-management and better patient adherence to treatments. Our results showed that this application can be used as a successful tool for hypertension self-management in patients attending public hospitals in developing countries. Iran Randomized Clinical Trial Center IRCT2015111712211N2 . Registered on 1 January 2016.
Sections du résumé
BACKGROUND
BACKGROUND
Self-management of hypertension is of great significance given its increasing incidence and its associated disabilities. In view of the increased use of mobile health in medicine, the present study evaluated the effect of a self-management application on patient adherence to hypertension treatment.
METHODS
METHODS
This clinical trial was performed on 120 hypertensive patients who were provided with a mobile intervention for 8 weeks and followed up until the 24th week. Data on the primary outcome (adherence to treatment) and secondary outcomes (adherence to the DASH diet, regular monitoring of blood pressure, and physical activity) were collected using a questionnaire and a mobile application, respectively. The inter-group change difference over time was analyzed using repeated measures ANOVA (general linear model).
RESULTS
RESULTS
The treatment adherence score increased by an average of 5.9 (95% CI 5.0-6.7) in the intervention group compared to the control group. The scores of "adherence to the low-fat and low-salt diet plans" were 1.7 (95% CI 1.3-2.1) and 1.5 (95% CI 1.2-1.9), respectively. Moreover, moderate physical activity increased to 100.0 min (95% CI 61.7-138.3) per week in the intervention group.
CONCLUSION
CONCLUSIONS
The treatment and control of blood pressure require a multifaceted approach given its complexity and multifactorial nature. Considering the widespread use of smartphones, mHealth interventions can be effective in self-management and better patient adherence to treatments. Our results showed that this application can be used as a successful tool for hypertension self-management in patients attending public hospitals in developing countries.
TRIAL REGISTRATION
BACKGROUND
Iran Randomized Clinical Trial Center IRCT2015111712211N2 . Registered on 1 January 2016.
Identifiants
pubmed: 34167566
doi: 10.1186/s13063-021-05270-0
pii: 10.1186/s13063-021-05270-0
pmc: PMC8223338
doi:
Types de publication
Journal Article
Randomized Controlled Trial
Langues
eng
Sous-ensembles de citation
IM
Pagination
413Subventions
Organisme : The Global Oper Reserch Support Team
ID : 00990476
Références
J Hypertens. 2017 Jun;35(6):1133-1144
pubmed: 28306634
Lancet. 2016 Mar 5;387(10022):957-967
pubmed: 26724178
Health Psychol. 2010 Jan;29(1):40-9
pubmed: 20063934
Front Pharmacol. 2017 Mar 01;8:100
pubmed: 28298894
Br J Nutr. 2015 Jan 14;113(1):1-15
pubmed: 25430608
Aten Primaria. 2004 Nov 15;34(8):399-405
pubmed: 15546536
BMC Med Inform Decis Mak. 2015 Apr 29;15:36
pubmed: 25924825
BMC Endocr Disord. 2016 May 26;16(1):24
pubmed: 27230479
BMJ. 2012 Jul 09;345:e3953
pubmed: 22777025
Stroke. 2014 Jan;45(1):315-53
pubmed: 24309587
JAMA. 2017 Jan 10;317(2):165-182
pubmed: 28097354
Int J Clin Pract. 2015 Jan;69(1):9-32
pubmed: 25472682
J Eval Clin Pract. 2008 Jun;14(3):465-9
pubmed: 18373577
JAMA. 2014 Feb 5;311(5):507-20
pubmed: 24352797
Am J Prev Med. 2008 Jun;34(6):514-8
pubmed: 18471588
J Am Coll Cardiol. 2005 Sep 6;46(5):743-51
pubmed: 16139119
J Telemed Telecare. 2012 Jul;18(5):273-81
pubmed: 22826375
Curr Atheroscler Rep. 2017 Mar;19(3):12
pubmed: 28210974
Eur Respir J. 2008 Sep;32(3):651-9
pubmed: 18508824
Int J Chron Obstruct Pulmon Dis. 2009;4:301-13
pubmed: 19750190
J Telemed Telecare. 2014 Sep;20(6):293-9
pubmed: 24958355
Prog Cardiovasc Nurs. 2000 Summer;15(3):90-6
pubmed: 10951950
Am Heart J. 2017 Apr;186:40-47
pubmed: 28454831
Can J Cardiol. 2015 May;31(5):569-71
pubmed: 25795106
JMIR Mhealth Uhealth. 2015 Feb 18;3(1):e19
pubmed: 25693595
Cardiol Clin. 2017 Feb;35(1):99-115
pubmed: 27886793
Pediatr Nephrol. 2014 Sep;29(9):1507-16
pubmed: 24026758
Curr Hypertens Rev. 2014;10(3):134-41
pubmed: 25544289